[3] (a) S. Fustero, M.S. Rosello, P. Barrio, A.S. Fuentes, Chem.
Rev. 111 (2011) 6984-7034.
four-substituted pyrazole derivatives in moderate to good yield.
Further studies on the utility of this method are in progress.
(b) K. Karrouchi, M. Ansar, et al., Molecules 23 (2018) 134-220.
(c) J.S.S. Neto, G. Zeni, Chem. Eur. J. 26 (2020) 8175-189.
(d) Y.L. Janin, Chem. Rev. 112 (2012) 3924-3958.
(e) B. Eftekhari-Sis, M. Zirak, A. Akbari, Chem. Rev. 113
(2013) 2958-3043.
Conflict of interest
There are no conflicts to declare
.
[4] (a) A. Lévai, A.M.S. Silva, J. Jeko, et al., Eur. J. Org. Chem. 12
(2006) 2825-2832.
(b) S.K. Singh, M.S. Reddy, Y.K. Rao, et al., Tetrahedron Lett.
45 (2004) 7679-7682.
(c) Z.X. Wang, H.L. Qin, Green Chem. 6 (2004) 90-92.
(d) M.C. Bagley, M.C. Lubinu, C. Mason, Synlett. 5 (2007) 704-
708.
(e) G. Cabarrocas, M. Ventura, J.M. Villalgordo, Tetrahedron:
Asymmetry 11 (2000) 2483-2493.
(f) D.B. Grotjahn, S. Van, L. Mejorad, et al., J. Org. Chem. 67
(2002) 9200-9209.
Acknowledgments
This work is supported by the National Natural Science
Foundation of China (Nos. 21625205 and U19A2014).
References
[1] (a) L. Pizzutia, A.G. Barschakb, S. Moura, et al., Curr. Org.
Chem. 18 (2104) 115-126.
[5] (a) K. Mohanan, A.R. Martin, J.J. Vasseur, et al., Angew. Chem.
Int. Ed. 49 (2010) 3196-3199.
(b) M.S. Moreno, C. Marín, J. Pitarch, et al., J. Med. Chem. 55
(2012) 4231-4243.
(c) A. Ansari, A. Ali, M. Asif, Shamsuzzaman, New J. Chem. 41
(2017) 16-41.
(d) M.E. Monteiro, G. Lechuga, M.C.S. Pereira, et al., Eur. J.
Med. Chem. 182 (2019) 111610-111623.
(e) M.S.D. Santos, M.L.V. Oliveira, M.M.C. Cavalheiro, et al.,
Bioorg. Med. Chem. Lett. 21 (2011) 7451-7454.
(f) B.F. Ruan, Y.Z, Zhu, W.D. Liu, B.A. Song, Y.P. Tian, Eur. J.
Med. Chem. 72 (2014) 46-51
(b) Z. Chen, Y. Zhang, J. Nie, J.A. Ma, Org. Lett. 20 (2018)
2120-2124.
(c) P.K. Mykhailiuk, Eur. J. Org. Chem. 33 (2015) 7235-7239.
[6] D. Drikermann, V. Kerndl, H. Görls, I. Vilotijevic, Synlett. 31
(2020) 1158-1162.
[7] (a) M.P. Doyle, M.A. McKervey, T. Ye, Modern Catalytic
Methods for Organic Synthesis with Diazo Compounds: From
Cyclopropanes to Ylides, Wiley, New York, 1998.
(b) A. Ford, H. Miel, M.A. McKervey, et al., Chem. Rev. 115
(2015) 9981-10080.
[8] (a) A. Padwa, W.H. Pearson, Synthetic Applications of 1,3-
Dipolar Cycloaddi-tion Chemistry toward Heterocycles and
Natural Products, John Wiley and Sons; New York, 2002.
(b) A. Arrieta, J.R. Carrillo, A. Morenn, et al., Tetrahedron 54
(1998) 13167-13168.
(g) M.F. Khan, M.M. Alam, M. Shaquiquzzaman, et al., Eur. J.
Med. Chem. 120 (2016) 170-201
(h) J.V. Faria, P.F. Vegi, A.M.R. Bernardino, et al., Bioorg.
Med. Chem. 25 (2017) 5891-5903.
[2] (a) L. Leroy, S. Cousin, A. Italiano, Eur. J. Cancer 81 (2017)
102-105.
(c) S. Kobayashi, R. Hirabayashi, Y. Yamashita, et al.
Tetrahedron Lett. 44 (2003) 3351-3354.
(b) J.A. Balfour, H.M. Bryson, R.N. Brogden, Drugs 51 (1996)
99-136.
(c) M.M. Buckley, R.N. Brogden, K.L. Goa, et al., Drugs 44
(1992) 408-444.
(d) A. Sadurn, G. Kehr, R. Gilmour, et al., Chem. Eur. J. 24
(2018) 2832-2836.
(e) M.S. McClure, M.B. Berry, J. Powers, et al., Eur. J. Org.
Chem. 19 (2012) 3561-3565.
(f) D.W. Graham, W.T. Ashton, E.F. Rogers, et al., J. Med.
Chem. 30 (1987) 1074-1090.
(g) P.G. Middleton, M.A. Mall, R. Jain, et al., N. Engl. J. Med.
381 (2019) 1809-1819.
(h) T. Nishina1, S. Takahashi, T. Doi, et al., Invest. New Drugs
36 (2018) 424-434.
(d) L. Wu, M. Shi, J. Org. Chem. 75 (2010) 2296-2301.
(e) N. Jiang, C.J. Li, Chem. Commun. 2004, 394-395.
(f) Y. Li, L. Liu, J. Zhang, Org. Lett. 20 (2018) 6444−6448.
[9] (a) P.R. Krishna, E.R. Sekhar, F. Mongin, Tetrahedron Lett. 49
(2008) 6768-6772.
(b) X. Qi, J.M. Ready, Angew. Chem. Int. Ed. 46 (2007) 3242-
3244.
(c) N.A. McGrath, R.T. Raines, Chem. Sci. 3 (2012) 3237-3240.
(d) P. Zhao, S. Wu, C. Ke, X. Liu, X. Feng, Chem. Commun. 54
(2018) 9837-9840.
[10] X. Yi, J. Feng, F. Huang, J.B. Baell, Chem. Commun. 56 (2020)
1243-1246.
[11] J. Shao, W. Chen, M. Zhao, et al., Org. Lett. 20 (2018) 3992-
3995.